My Profile
Matthew Goldstein
Raising intellectual capital on Wall Street
See all posts
Thu 26 Nov 2009 | 9:50 EST
You are here:
Home
>
Business & Finance
>
Stocks
> Officers and Directors
Home
Business & Finance
Markets
Deals
Small Business
Green Business
Industries
Industry Summits
Stocks
Advanced Stock Search
Overview
Option Quote
Chart
Officers and Directors
Key Developments
Company News
Press Releases
Financial Highlights
Ratios
Financial Statements
Performance
Insider Trading
Institutional Holders
Estimates
Recommendations
Analyst Research
Funds
ETFs
Currencies
Commodities
Options
Economy
Bonds
Analyst Research
Portfolio
News
Do More With Reuters
RSS
Widgets
Mobile
Podcasts
Newsletters
Your View
Make Reuters My Homepage
Partner Services
CareerBuilder
Affiliate Network
Professional Products
Support (Customer Zone)
Reuters Media
Financial Products
About Thomson Reuters
Officers and Directors For Antigenics Inc.
Antigenics Inc. (AGEN.O) (Consolidated Issue listed on NASDAQ Capital Market)
sector:
Healthcare
.
industry:
Pharmaceuticals - Generic & Specialty
ยท
View
AGEN
on other exchanges
As of 25 Nov 2009
0.76
USD
Price Change
-0.03
Percent Change
-3.80%
Analyst Recommendations
Research Another Stock:
Symbol Look-up
Independent Research
|
Broker Research
Summary
Biographies
Basic Compensation
Options Compensation
Name
Age
Since
Current Position
Valentine, Karen
37
2008
Vice President, General Counsel
Klaskin, Christine
43
2006
Vice President - Finance, Principal Accounting Officer
Wentworth, Kerry
36
--
Vice President - Clinical Operations and Regulatory Affairs
Dechaene, Tom
49
2006
Lead Director
Eisen, Margaret
54
2003
Director
Jordan, Wadih
74
2003
Director
Levitsky, Hyam
50
2006
Director
Wright, Timothy
51
2006
Director
Corvese, Brian
51
2007
Director
Hatsopoulos, John
75
2007
Director
Rothwell, Timothy
51
2009
Director
Sharp, Shalini
34
2006
Chief Financial Officer, Vice President
Armen, Garo
56
1999
Chairman of the Board, Chief Executive Officer
Find out more about AGEN.O
Insider Trading